SITC Cancer Immunotherapy Guidelines - Cutaneous Melanoma 2.0 Recorded Webinar

View Recorded Webinar

 

On July 30, 2018, leading experts in cancer immunotherapy presented an overview of the updated SITC Cancer Immunotherapy Guidelines - Cutaneous Melanoma manuscript at a live webinar.

 

Webinar Faculty

Michael B. Atkins, MD - Georgetown-Lombardi Comprehensive Cancer Center

John M. Kirkwood, MD - UPMC Hillman Cancer Center

Ryan J. Sullivan, MD - Massachusetts General Hospital

 

Webinar Date

July 30, 2018

 

Please note that the recorded webinar is not available for continuing education credits.

SITC Cancer Immunotherapy Guidelines - Cutaneous Melanoma Recorded Webinar

On July 30, 2018, leading experts in cancer immunotherapy presented an overview of the recently updated SITC Cancer Immunotherapy Guidelines - Cutaneous Melanoma at a live webinar.

 

The webinar faculty presented and discussed:

  • The role of immunotherapy for the treatment of melanoma
  • The role of patient biomarker testing for prognostic use as well as optimizing treatment selection
  • Unique disease cases that may require adaption of immunotherapy utilization
  • How best to manage immune-related adverse events

 

A dedicated question-and-answer session at the end of the webinar provided an opportunity for attendees to converse with the faculty and ask questions about the guideline recommendations.

Individual topic purchase: Selected